We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
(+4.4%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$34.9M |
| 2 |
Williams Companies
WMB
|
+$16.4M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$11.4M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$10.6M |
| 5 |
Arista Networks
ANET
|
+$9.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$102M |
| 2 |
XL
XL Group Ltd.
XL
|
+$28.4M |
| 3 |
Microsoft
MSFT
|
+$26.9M |
| 4 |
Cisco
CSCO
|
+$24.2M |
| 5 |
GGP
GGP Inc.
GGP
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Financials | 15.87% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Atara Biotherapeutics
ATRA
$74.3M
| $1.54M | ﹤0.01% |
1,490
-80
| -5% | -$78.2K |
|
1802
Eagle Bancorp
EGBN
$849M
| $1.53M | ﹤0.01% |
30,252
-1,621
| -5% | -$89.9K |
|
|
GHDX
1803
DELISTED
Genomic Health, Inc.
GHDX
| $1.53M | ﹤0.01% |
21,733
-260
| -1% | -$15.2K |
|
|
NVRO
1804
DELISTED
NEVRO CORP.
NVRO
| $1.52M | ﹤0.01% |
26,757
-1,768
| -6% | -$111K |
|
|
FRGI
1805
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.52M | ﹤0.01% |
56,991
-6,487
| -10% | -$186K |
|
1806
Anika Therapeutics
ANIK
$270M
| $1.52M | ﹤0.01% |
36,092
+244
| +0.7% | +$9.64K |
|
|
TSRO
1807
DELISTED
TESARO, Inc.
TSRO
| $1.52M | ﹤0.01% |
38,858
-929
| -2% | -$32.8K |
|
|
IPHI
1808
DELISTED
INPHI CORPORATION
IPHI
| $1.51M | ﹤0.01% |
39,893
-2,825
| -7% | -$97.4K |
|
1809
Arrowhead Research
ARWR
$12.1B
| $1.51M | ﹤0.01% |
78,815
-5,167
| -6% | -$84.8K |
|
|
HSII
1810
DELISTED
Heidrick & Struggles
HSII
| $1.51M | ﹤0.01% |
44,555
-831
| -2% | -$32.4K |
|
|
VIVO
1811
DELISTED
Meridian Bioscience Inc
VIVO
| $1.5M | ﹤0.01% |
100,998
-3,206
| -3% | -$49.7K |
|
1812
Builders FirstSource
BLDR
$7.8B
| $1.5M | ﹤0.01% |
102,403
-7,072
| -6% | -$120K |
|
1813
CEVA Inc
CEVA
$992M
| $1.5M | ﹤0.01% |
52,253
-1,315
| -2% | -$39.7K |
|
1814
CorVel
CRVL
$3.19B
| $1.5M | ﹤0.01% |
74,775
-4,371
| -6% | -$84.3K |
|
|
MNR
1815
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.5M | ﹤0.01% |
89,853
-387
| -0.4% | -$6.53K |
|
|
AYR
1816
DELISTED
Aircastle Ltd
AYR
| $1.5M | ﹤0.01% |
68,459
+5,063
| +8% | +$105K |
|
1817
Groupon
GRPN
$955M
| $1.5M | ﹤0.01% |
19,844
-1,389
| -7% | -$122K |
|
1818
WSFS Financial
WSFS
$4.2B
| $1.49M | ﹤0.01% |
31,633
-2,941
| -9% | -$151K |
|
1819
Extreme Networks
EXTR
$3.18B
| $1.49M | ﹤0.01% |
271,023
-5,042
| -2% | -$35.8K |
|
1820
Cannae Holdings
CNNE
$652M
| $1.48M | ﹤0.01% |
70,669
+811
| +1% | +$15.9K |
|
|
AYX
1821
DELISTED
Alteryx Inc
AYX
| $1.48M | ﹤0.01% |
25,872
-1,280
| -5% | -$65.2K |
|
1822
Century Aluminum
CENX
$4.55B
| $1.48M | ﹤0.01% |
123,469
+272
| +0.2% | +$3.5K |
|
1823
Metallus
MTUS
$888M
| $1.48M | ﹤0.01% |
99,297
+1,319
| +1% | +$19.8K |
|
|
LADR
1824
Ladder Capital
LADR
$1.21B
| $1.46M | ﹤0.01% |
86,415
+257
| +0.3% | +$4.29K |
|
|
IMPV
1825
DELISTED
Imperva, Inc.
IMPV
| $1.46M | ﹤0.01% |
31,523
-2,218
| -7% | -$107K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2018 Portfolio in Review
As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
- RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
- RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
- RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
- RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
- RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.